This Viewpoint describes the use of broad molecular marker testing in patients with early-stage non–small cell lung cancer. Click to show full abstract
This Viewpoint describes the use of broad molecular marker testing in patients with early-stage non–small cell lung cancer.
               
Click one of the above tabs to view related content.